VARESPLADIB SODIUM (LY315920 SODIUM SALT)

Background Information:

Varespladib Sodium is a secretory phospholipase A2 (sPLA2) inhibitor,
a water-soluble Intravenous version of the molecule Varespladib,
currently being evaluated as an anti-inflammatory sPLA2 inhibitor for
the prevention of acute chest syndrome (ACS), the leading cause of death
for patients with sickle-cell disease.

APIM050365: VARESPLADIB SODIUM (LY315920 SODIUM SALT)

CAS No.: 172733-42-5.
Molecular Formula: C21H19N2O5Na.
Molecular Weight: 402.4.
Purity: 99.9% by HPLC at 214and 254 nm.
QC: HPLC, 1H-NMR, and quantitative elemental analysis report.
Solubility: Soluble in water (20.1mg/ml, >50 mM).
Storage: Refer to certificate of analysis.